Effect of a combination therapy between IL-12 and soluble IL-4 receptor (sIL-4R) on Candida albicans and herpes simplex virus type 1 infections in thermally injured mice

Canadian Journal of Microbiology

Volumn 48, Issue 10, 2002, Pages 886-894

  Kobayashi, Makiko ^a   Takahashi, Hitoshi ^a   Herndon, David N ^b   Pollard, Richard B ^c   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Burn; Candida albicans; Herpesvirus; IL 12; Soluble IL 4 receptor

Indexed keywords

ANTIBODIES; THERMAL EFFECTS; VIRUSES;

COMBINATION THERAPY;

MICROBIOLOGY;

CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4 RECEPTOR; MONOCLONAL ANTIBODY; INTERLEUKIN 4;

VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CANDIDA ALBICANS; CANDIDIASIS; CULTURE MEDIUM; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THERMAL INJURY; TREATMENT PLANNING; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DRUG COMBINATION; DRUG EFFECT; IMMUNOLOGY; MACROPHAGE; MICROBIOLOGY; SPLEEN; TREATMENT OUTCOME;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

ANIMALS; BURNS; CANDIDA ALBICANS; CANDIDIASIS; DRUG THERAPY, COMBINATION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; INTERLEUKIN-12; INTERLEUKIN-4; MACROPHAGES; MICE; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN-4; SPLEEN; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 0036783021     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w02-085     Document Type: Article

References (44)

1. Barlow, Y. 1994. T lymphocytes and immunosuppression in the burned patients: a review. Burns, 20: 487-490.
2. Bodey, G.P. 1997. New fungal pathogens. In Current clinical topics in infectious diseases. Edited by J.S. Remington and M.N. Swartz. Blackwell Science Ltd., Paris, France. pp. 205-235.
3. Byers, R.J., Hasleton, P.S., Quigley, A., Dennett, C., Klapper, P.E., Cleator, G.M., and Faragher, E.B. 1996. Pulmonary herpes in burns patients. Eur. Respir. J. 9: 2313-2317.
4. Decker, D., Schondorf, M., Bidlingmaier, F., Hirner, A., and von Ruecker, A.A. 1996. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery (St. Louis), 119: 316-325.
5. Del Prete, G., and Romagnani, S. 1994. The role of Th1 and Th2 subsets in human infectious diseases. Trends Microbiol. 2: 4-6.
6. Demling, R.H., and LaLonde, C. 1989. Burn trauma. Thieme Medical Publishers, New York.
7. Fernandez-Botran, R., and Vitetta, E.S. 1991. Evidence that murine soluble interleukin 4 receptors may act as transport proteins. J. Exp. Med. 174: 673-681.
8. Field, H.J. 1988. Antiviral agents: the development and assessment of antiviral chemotherapy. Vol. 1: The development of antiviral drug resistance. Edited by H.J. Field. CRC Press Inc., Boca Raton, Florida. pp. 127-149.
9. Fitch, F.W., Mckisic, M.D., Lancki, D.W., and Gajewski, T.F. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11: 29-48.
10. Furukawa, K., Kobayashi, M., Herndon, D.N., Pollard, R.B., and Suzuki, F. 2002. Appearance of MCP-1 early after thermal injury: a role on the subsequent development of burn-associated type 2 T-cell responses. Ann. Surg. 236: 122-119.
11. Guler, M.L., Gorham, J.D., Hsieh, C.S., Mackey, A.J., Steen, R.G., Dietrich, W.F., and Murphy, K.M. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science (Washington, D.C.), 271: 984-987.
12. Hof, H. 1991. Therapeutic activities of antibiotics in listeriosis. Infection, 19: S229-S233.
13. Kagan, R.J., Naraqi, S., Matsuda, T., and Jonasson, O.M. 1985. Herpes simplex virus and cytomegalovirus infections in burned patients. J. Trauma, 25: 40-45.
14. Klein, D.G., Fritsch, D.E., and Amin, S.G. 1995. Wound infection following trauma and burn injuries. Crit. Care Nurs. Clin. North America, 7: 627-642.
15. Kobayashi, H., Kobayashi, M., Utsunomiya, T., Herndon, D.N., Pollard, R.B., and Suzuki, F. 1999. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J. Immunol. 162: 7148-7154.
16. Kobayashi, H., Kobayashi, M., Takahashi, H., Herndon, D.N., Pollard, R.B., and Suzuki, F. 2002. Soluble IL-4 receptor improves the skin-graft-associated cytomegalovirus infection in thermally injured mice. Burns, In press.
17. + contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV. J. Leukoc. Biol. 58: 159-167.
18. + type 2 T cells. J. Leukoc. Biol. 63: 723-731.
19. Kobayashi, M., Mori, K., Kobayashi, H., Pollard, R.B., and Suzuki, F. 1998b. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine: Part 1. Antiviral and antifungal activities in thermally injured mice. Immunol. Cell Biol. 76: 202-208.
20. Linares, H.A. 1982. A report of 115 consecutive autopsies in burned children. Burns, 8: 263-270.
21. Ma, X., Aste-Amezaga, M., Gri, G., Gerosa, F., and Trinchieri, G. 1997. Immunomodulatory functions and molecular regulation of IL-12. Chem. Immunol. 68: 1-22.
22. Magram, J., Sfarra, J., Connaughton, S., Faherty, D., Warrier, R., Carvajal, D., Wu, C.Y., Stewart, C., Sarmiento, U., and Gately, M.K. 1996. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann. N.Y. Acad. Sci. 795: 60-70.
23. Matsuo, R., Kobayashi, M., Herndon, D.N., Pollard, R.B., and Suzuki, F. 1996. Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J. Leukoc. Biol. 59: 623-630.
24. Mosmann, T.R., and Coffman, R.L. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
25. Odds, F.C. 1979. Ecology and epidemiology of Candida. In Candida and Candidosis. Edited by F.C. Odds. University Park Press, Baltimore. pp. 50-74.
26. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity, 8: 275-283.
27. O'Sullivan, S.T., Lederer, J.A., Horgan, A.F., Chin, D.H.L., Mannick, J.A., and Rodrick, M.L. 1995. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222: 482-492.
28. Pensler, J.M., Herndon, D.N., Ptak, H., Bonds, E., Rutan, T.C., Desai, M.H., and Abston, S. 1986. Fungal sepsis: an increasing problem in major thermal injuries. J. Burn Care Rehabil. 7: 488-491.
29. Puccetti, P., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Enssle, K.H., Romani, L., and Bistoni, F. 1994. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis. 169: 1325-1331.
30. Romagnani, S. 1996. Understanding the role of Th1/Th2 cells in infection. Trends Microbiol. 4: 470-473.
31. Romani, L., Mencacci, A., Grohmann, U., Mocci, S., Mosci, P., Puccetti, P., and Bistoni, F. 1992. Neutralizing antibody to interleukin 4 induces protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. 176: 19-25.
32. Romani, L., Mencacci, A., Tonnetti, L., Spaccapelo, R., Cenci, E., Puccetti, P., Wolf, S.F., and Bistoni, F. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153: 5167-5175.
33. Rubin, R.H. 1993. Fungal and bacterial infections in immunocompromised host. Eur. J. Clin. Microbiol. Infect. Dis. 12: S42-S48.
34. Scott, J.L., and Farrell, J.P. 1996. In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis. Infect. Immun. 64: 5248-5254.
35. Seeman, J., Konigova, R., and Lysenkova, I. 1980. Fatal outcome of cytomegalovirus infections in severe burns. Acta Chir. Plast. 22: 166-170.
36. Spaccapelo, R., Del Sero, G., Mosci, P., Bistoni, F., and Romani, L. 1997. Early T cell unresponsiveness in mice with candidiasis and reversal by IL-2. J. Immunol. 158: 2294-2302.
37. Spebar, M.J., and Pruitt, B.A. 1981. Candidiasis in the burned patient. J. Trauma, 21: 237-239.
38. Still, J.M., Jr., Belcher, K., and Law, E.J. 1995. Management of Candida septicaemia in a regional burn unit. Burns, 21: 594-596.
39. + burn-associated type 2 T cells in cultures of peripheral blood mononuclear cells from patients with large burn injuries. FASEB. J. 13: A321.
40. Swain, S.L., Weinberg, A.D., English, M., and Huston, G. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145: 3796-3806.
41. Takagi, K., Suzuki, F., Barrow, R.E., Wolf, S.E., Kobayashi, M., and Herndon, D.N. 1998. Growth hormone improves the resistance of thermally injured mice infected with herpes simplex virus type 1. J. Trauma, 44: 517-522.
42. Utsunomiya, T., Kobayashi, M., Herndon, D.N., Pollard, R.B., and Suzuki, F. 1999. Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice. Clin. Exp. Immunol. 116: 291-298.
43. Utsunomiya, T., Kobayashi, M., Herndon, D.N., Pollard, R.B., and Suzuki, F. 2001. A mechanism of IL-12 unresponsiveness associated with thermal injury. J. Surg. Res. 96: 211-217.
44. Vazquez-Torres, A., Jones-Carson, J., and Balish, E. 1994. Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice. J. Infect. Dis. 170: 180-188.